Davidson Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Sell
570,345
-8,111
-1% -$212K 0.56% 64
2026
Q1
$16.2M Buy
578,456
+20,649
+4% +$550K 0.7% 58
2025
Q4
$13.9M Sell
557,807
-34,724
-6% -$876K 0.58% 68
2025
Q3
$15.1M Sell
592,531
-3,721
-0.6% -$91.8K 0.64% 66
2025
Q2
$14.5M Buy
596,252
+185,733
+45% +$4.33M 0.65% 67
2025
Q1
$10.4M Buy
410,519
+59,915
+17% +$1.57M 0.51% 72
2024
Q4
$9.3M Sell
350,604
-100,344
-22% -$2.72M 0.45% 76
2024
Q3
$13.1M Buy
450,948
+8,826
+2% +$257K 0.63% 71
2024
Q2
$12.4M Sell
442,122
-6,112
-1% -$168K 0.64% 69
2024
Q1
$12.4M Buy
448,234
+110,313
+33% +$3.06M 0.65% 71
2023
Q4
$9.73M Sell
337,921
-7,489
-2% -$226K 0.56% 73
2023
Q3
$11.5M Buy
345,410
+5,198
+2% +$184K 0.73% 65
2023
Q2
$12.5M Buy
340,212
+318
+0.1% +$12.4K 0.79% 64
2023
Q1
$13.9M Buy
339,894
+947
+0.3% +$40.9K 0.91% 53
2022
Q4
$17.4M Sell
338,947
-4,607
-1% -$221K 1.35% 21
2022
Q3
$15M Buy
343,554
+11,099
+3% +$539K 1.26% 24
2022
Q2
$17.4M Buy
332,455
+388
+0.1% +$19.8K 1.48% 19
2022
Q1
$17.2M Buy
332,067
+2,624
+0.8% +$136K 1.25% 25
2021
Q4
$19.5M Sell
329,443
-108,308
-25% -$5.37M 1.39% 22
2021
Q3
$18.8M Sell
437,751
-3,895
-0.9% -$173K 1.47% 21
2021
Q2
$17.3M Sell
441,646
-13,941
-3% -$542K 1.38% 23
2021
Q1
$16.5M Sell
455,587
-15,667
-3% -$556K 1.4% 24
2020
Q4
$17.3M Sell
471,254
-32,698
-6% -$1.2M 1.6% 19
2020
Q3
$17.5M Sell
503,952
-23,380
-4% -$820K 1.87% 14
2020
Q2
$16.4M Buy
527,332
+29,008
+6% +$985K 1.81% 15
2020
Q1
$15.4M Sell
498,324
-17,320
-3% -$590K 1.99% 13
2019
Q4
$19.2M Sell
515,644
-4,391
-0.8% -$156K 1.86% 14
2019
Q3
$17.7M Sell
520,035
-32,299
-6% -$1.17M 1.84% 13
2019
Q2
$22.7M Sell
552,334
-13,165
-2% -$523K 2.37% 9
2019
Q1
$22.8M Sell
565,499
-9,238
-2% -$370K 2.39% 10
2018
Q4
$23.8M Buy
574,737
+5,262
+0.9% +$218K 2.76% 8
2018
Q3
$23.8M Buy
569,475
+4,314
+0.8% +$166K 2.37% 9
2018
Q2
$19.5M Sell
565,161
-6,558
-1% -$224K 2.04% 10
2018
Q1
$19.3M Sell
571,719
-15,332
-3% -$527K 2.07% 10
2017
Q4
$20.2M Buy
587,051
+2,360
+0.4% +$80.5K 2.09% 11
2017
Q3
$19.8M Buy
584,691
+91,697
+19% +$2.95M 2.14% 9
2017
Q2
$15.7M Sell
492,994
-66,896
-12% -$2.11M 2.22% 10
2017
Q1
$18.2M Buy
559,890
+35,002
+7% +$1.1M 2.35% 9
2016
Q4
$16.2M Buy
524,888
+31,896
+6% +$974K 2.3% 8
2016
Q3
$15.8M Buy
492,992
+17,113
+4% +$572K 2.42% 7
2016
Q2
$15.9M Buy
475,879
+19,344
+4% +$617K 2.66% 6
2016
Q1
$12.8M Buy
456,535
+59,209
+15% +$1.69M 2.17% 8
2015
Q4
$12.2M Buy
397,326
+23,403
+6% +$736K 2.02% 9
2015
Q3
$11.1M Sell
373,923
-51,011
-12% -$1.64M 2.02% 12
2015
Q2
$13.5M Buy
424,934
+52,110
+14% +$1.7M 2.03% 10
2015
Q1
$12.3M Sell
372,824
-3,339
-0.9% -$106K 1.84% 13
2014
Q4
$11.1M Sell
376,163
-344,799
-48% -$9.89M 1.67% 15
2014
Q3
$19.9M Buy
720,962
+351,256
+95% +$9.86M 1.58% 15
2014
Q2
$10.4M Buy
369,706
+34,497
+10% +$983K 1.52% 18
2014
Q1
$10.2M Sell
335,209
-3,646
-1% -$109K 1.55% 17
2013
Q4
$9.85M Sell
338,855
-5,218
-2% -$152K 1.5% 16
2013
Q3
$9.38M Buy
344,073
+342,720
+25,330% +$9.32M 1.51% 15
2013
Q2
$35K Buy
+1,353
New +$37.4K 0.01% 161

Other funds holding PFE

Davidson Investment Advisors's PFE Position: Q2 2026 in Review

Davidson Investment Advisors reduced its Pfizer (PFE) stake by 1.4% in Q2 2026, selling an estimated $212K and leaving 570,345 shares worth $13.7M. The position accounts for 0.56% of the portfolio, ranked #64.

Davidson Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.8M in Q3 2018. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Davidson Investment Advisors held 570,345 shares of Pfizer worth $13.7M as of Q2 2026.
  • Davidson Investment Advisors sold 8,111 Pfizer shares in Q2 2026, an estimated $212K.
  • Pfizer made up 0.56% of Davidson Investment Advisors's portfolio in Q2 2026, its #64 holding.
  • Davidson Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Davidson Investment Advisors's Pfizer position peaked at $23.8M in Q3 2018.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Davidson Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.